Product Images Oxcarbazepine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 18 images provide visual information about the product associated with Oxcarbazepine NDC 70377-117 by Biocon Pharma Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

bottle-label.jpg - bottle label

bottle-label.jpg - bottle label

This text provides information on the storage and usage of an oral suspension of Oxcarbazepine, with a dosage of 300 mg per 5 ml. It highlights the need to store the medication in its original container at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication guide enclosed or provided separately contains essential information for the patient. It also emphasizes the importance of shaking the suspension well before use. The product is manufactured by Carnegie Pharmaceuticals LLC for Biocon Pharma Inc. in Iselin, New Jersey, USA.*

carton - carton

carton - carton

This is a description for Oxcarbazepine Oral Suspension, USP. Each 5 mL of the suspension contains 300 mg of oxcarbazepine. It is important to shake well before use. The medication guide should be provided to each patient. The suspension should be stored in its original container at a temperature between 20°C and 25°C. It is essential to keep this medication and all drugs out of the reach of children. Once opened, the suspension should be used within 7 weeks.*

oxcarbazepine-fgure1 - oxcarbazepine fgure1

oxcarbazepine-fgure1 - oxcarbazepine fgure1

oxcarbazepine-fgure10 - oxcarbazepine fgure10

oxcarbazepine-fgure10 - oxcarbazepine fgure10

oxcarbazepine-fgure11 - oxcarbazepine fgure11

oxcarbazepine-fgure11 - oxcarbazepine fgure11

oxcarbazepine-fgure12 - oxcarbazepine fgure12

oxcarbazepine-fgure12 - oxcarbazepine fgure12

oxcarbazepine-fgure13 - oxcarbazepine fgure13

oxcarbazepine-fgure13 - oxcarbazepine fgure13

oxcarbazepine-fgure14 - oxcarbazepine fgure14

oxcarbazepine-fgure14 - oxcarbazepine fgure14

oxcarbazepine-fgure15 - oxcarbazepine fgure15

oxcarbazepine-fgure15 - oxcarbazepine fgure15

oxcarbazepine-fgure16 - oxcarbazepine fgure16

oxcarbazepine-fgure16 - oxcarbazepine fgure16

oxcarbazepine-fgure2 - oxcarbazepine fgure2

oxcarbazepine-fgure2 - oxcarbazepine fgure2

oxcarbazepine-fgure3 - oxcarbazepine fgure3

oxcarbazepine-fgure3 - oxcarbazepine fgure3

oxcarbazepine-fgure4 - oxcarbazepine fgure4

oxcarbazepine-fgure4 - oxcarbazepine fgure4

oxcarbazepine-fgure6 - oxcarbazepine fgure6

oxcarbazepine-fgure6 - oxcarbazepine fgure6

oxcarbazepine-fgure7 - oxcarbazepine fgure7

oxcarbazepine-fgure7 - oxcarbazepine fgure7

oxcarbazepine-fgure8 - oxcarbazepine fgure8

oxcarbazepine-fgure8 - oxcarbazepine fgure8

oxcarbazepine-fgure9 - oxcarbazepine fgure9

oxcarbazepine-fgure9 - oxcarbazepine fgure9

oxcarbazepine-structure - oxcarbazepine structure

oxcarbazepine-structure - oxcarbazepine structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.